135 related articles for article (PubMed ID: 32066096)
21. Electrophysiological Studies to Detect Peripheral Neuropathy in Children Treated With Vincristine.
Kavcic M; Koritnik B; Krzan M; Velikonja O; Prelog T; Stefanovic M; Debeljak M; Jazbec J
J Pediatr Hematol Oncol; 2017 May; 39(4):266-271. PubMed ID: 28375940
[TBL] [Abstract][Full Text] [Related]
22. Long-term peripheral neuropathy symptoms in breast cancer survivors.
Mustafa Ali M; Moeller M; Rybicki L; Moore HCF
Breast Cancer Res Treat; 2017 Nov; 166(2):519-526. PubMed ID: 28791499
[TBL] [Abstract][Full Text] [Related]
23. Nerve lesions after therapy for childhood acute lymphoblastic leukemia.
Harila-Saari AH; Vainionpää LK; Kovala TT; Tolonen EU; Lanning BM
Cancer; 1998 Jan; 82(1):200-7. PubMed ID: 9428498
[TBL] [Abstract][Full Text] [Related]
24. Pediatric chemotherapy induced peripheral neuropathy: A systematic review of current knowledge.
Kandula T; Park SB; Cohn RJ; Krishnan AV; Farrar MA
Cancer Treat Rev; 2016 Nov; 50():118-128. PubMed ID: 27664395
[TBL] [Abstract][Full Text] [Related]
25. Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy.
Park SB; Lin CS; Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC
Brain; 2009 Oct; 132(Pt 10):2712-23. PubMed ID: 19745023
[TBL] [Abstract][Full Text] [Related]
26. Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies.
Carozzi VA; Canta A; Oggioni N; Sala B; Chiorazzi A; Meregalli C; Bossi M; Marmiroli P; Cavaletti G
Exp Neurol; 2010 Dec; 226(2):301-9. PubMed ID: 20832406
[TBL] [Abstract][Full Text] [Related]
27. Changes in excitability properties associated with axonal regeneration in human neuropathy and mouse Wallerian degeneration.
Sawai S; Kanai K; Nakata M; Hiraga A; Misawa S; Isose S; Hattori T; Kuwabara S
Clin Neurophysiol; 2008 May; 119(5):1097-105. PubMed ID: 18342570
[TBL] [Abstract][Full Text] [Related]
28. Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity.
Bianchi R; Brines M; Lauria G; Savino C; Gilardini A; Nicolini G; Rodriguez-Menendez V; Oggioni N; Canta A; Penza P; Lombardi R; Minoia C; Ronchi A; Cerami A; Ghezzi P; Cavaletti G
Clin Cancer Res; 2006 Apr; 12(8):2607-12. PubMed ID: 16638873
[TBL] [Abstract][Full Text] [Related]
29. Challenges Evaluating Chemotherapy-Induced Peripheral Neuropathy in Childhood Cancer Survivors.
Mohrmann C; Armer J; Hayashi RJ
J Pediatr Oncol Nurs; 2017; 34(2):106-114. PubMed ID: 27251891
[TBL] [Abstract][Full Text] [Related]
30. Electroclinical biomarkers of early peripheral neurotoxicity from oxaliplatin.
McHugh JC; Tryfonopoulos D; Fennelly D; Crown J; Connolly S
Eur J Cancer Care (Engl); 2012 Nov; 21(6):782-9. PubMed ID: 22594346
[TBL] [Abstract][Full Text] [Related]
31. Determinants of ototoxicity in 451 platinum-treated Dutch survivors of childhood cancer: A DCOG late-effects study.
Clemens E; de Vries AC; Pluijm SF; Am Zehnhoff-Dinnesen A; Tissing WJ; Loonen JJ; van Dulmen-den Broeder E; Bresters D; Versluys B; Kremer LC; van der Pal HJ; van Grotel M; van den Heuvel-Eibrink MM;
Eur J Cancer; 2016 Dec; 69():77-85. PubMed ID: 27821322
[TBL] [Abstract][Full Text] [Related]
32. Peripheral neuropathy in children and adolescents treated for cancer.
Bjornard KL; Gilchrist LS; Inaba H; Diouf B; Hockenberry MJ; Kadan-Lottick NS; Bowers DC; Dolan ME; Ullrich NJ; Evans WE; Ness KK
Lancet Child Adolesc Health; 2018 Oct; 2(10):744-754. PubMed ID: 30236383
[TBL] [Abstract][Full Text] [Related]
33. [Chemotherapy-induced Peripheral Neuropathy].
Bobylev I; Elter T; Schneider C; Wunderlich G; Zimmer P; Streckmann F; Fink GR; Lehmann HC
Fortschr Neurol Psychiatr; 2015 Aug; 83(8):427-36. PubMed ID: 26327474
[TBL] [Abstract][Full Text] [Related]
34. Bortezomib-induced neuropathy: axonal membrane depolarization precedes development of neuropathy.
Nasu S; Misawa S; Nakaseko C; Shibuya K; Isose S; Sekiguchi Y; Mitsuma S; Ohmori S; Iwai Y; Beppu M; Shimizu N; Ohwada C; Takeda Y; Fujimaki Y; Kuwabara S
Clin Neurophysiol; 2014 Feb; 125(2):381-7. PubMed ID: 23973385
[TBL] [Abstract][Full Text] [Related]
35. Axonal dysfunction prior to neuropathy onset in type 1 diabetes.
Arnold R; Kwai N; Lin CS; Poynten AM; Kiernan MC; Krishnan AV
Diabetes Metab Res Rev; 2013 Jan; 29(1):53-9. PubMed ID: 23008000
[TBL] [Abstract][Full Text] [Related]
36. Patient-reported motor chemotherapy-induced peripheral neuropathy impacts function in advanced colorectal cancer survivors receiving chemotherapy: A cross-sectional study.
Hsieh CF; Chan YN; Wu CJ; Yen LY; Chang YC; Wang YJ
Jpn J Nurs Sci; 2023 Jul; 20(3):e12531. PubMed ID: 36960772
[TBL] [Abstract][Full Text] [Related]
37. [Neurologic complications of chemotherapy (vincristine etc.)].
Nomura K; Ohno R
Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):576-81. PubMed ID: 10434725
[No Abstract] [Full Text] [Related]
38. Multimodal quantitative examination of nerve function in colorectal cancer patients prior to chemotherapy.
Kandula T; Farrar MA; Krishnan AV; Murray J; Timmins HC; Goldstein D; Lin CS; Kiernan MC; Park SB
Muscle Nerve; 2018 Apr; 57(4):615-621. PubMed ID: 28881477
[TBL] [Abstract][Full Text] [Related]
39. Neurophysiological and clinical outcomes in chemotherapy-induced neuropathy in cancer.
Kandula T; Farrar MA; Kiernan MC; Krishnan AV; Goldstein D; Horvath L; Grimison P; Boyle F; Baron-Hay S; Park SB
Clin Neurophysiol; 2017 Jul; 128(7):1166-1175. PubMed ID: 28511129
[TBL] [Abstract][Full Text] [Related]
40. Associations between long-term serum platinum and neurotoxicity and ototoxicity, endocrine gonadal function, and cardiovascular disease in testicular cancer survivors.
Hjelle LV; Bremnes RM; Gundersen POM; Sprauten M; Brydøy M; Tandstad T; Wilsgaard T; Fosså SD; Oldenburg J; Haugnes HS
Urol Oncol; 2016 Nov; 34(11):487.e13-487.e20. PubMed ID: 27523611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]